What research is needed to assess the cost-effectiveness of ABPM and HBPM for CKD patients?
Research is needed to assess the cost-effectiveness of ABPM and HBPM for CKD patients, including comparing standardized unattended versus standardized attended AOBP in routine clinical practice, determining the optimal interval for repeating ABPM and HBPM among individuals not taking and taking antihypertensive medications, determining the proportion of CKD patients with white-coat hypertension, masked hypertension, the white-coat effect, and masked uncontrolled hypertension using a BP threshold of 120 mm Hg instead of 140 mm Hg, and assessing the cost-effectiveness of ABPM and HBPM separately. Additionally, RCTs comparing treatment based on ABPM or HBPM versus standardized of ce BP measurements should be conducted. 